Flerie AB (publ) (STO:FLERIE)

Market Cap	2.76B -21.8%
Revenue (ttm)	2.50M -3.8%
Net Income	-756.90M
EPS	-9.71
Shares Out	79.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,925
Average Volume	48,275
Open	34.60
Previous Close	34.70
Day's Range	33.90 - 34.65
52-Week Range	33.25 - 47.70
Beta	n/a
RSI	37.75
Earnings Date	Mar 5, 2026

About Flerie AB

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Employees: 7
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: FLERIE

Financial Performance

In 2025, Flerie AB's revenue was 2.50 million, a decrease of -3.85% compared to the previous year's 2.60 million. Losses were -756.90 million, 232.0% more than in 2024.